1. Introduction {#sec1-ijerph-17-04617}
===============

The World Health Organization (WHO) stated that one-quarter of global deaths, including one-third of child deaths, are related to environmental factors that can be improved \[[@B1-ijerph-17-04617]\]. In countries with low economic levels, environmental factors significantly contribute to the incidence of disease and death. In many developing countries, economic policies are rather geared towards achieving higher real economic growth rates; and policies that tackle environmental challenges in this process are relatively neglected \[[@B2-ijerph-17-04617]\].

Asia includes the adjacent islands of the continent, the Indian Ocean and the Pacific, and the Asian continent accounts for approximately 60% of the world's population \[[@B3-ijerph-17-04617]\]. Depending on the level of development, countries in Asia are subject to air pollution arising from increased urbanization, low-grade fossil fuel use, indoor air pollution from biofuels, heavy metal pollution from mine development, water pollution from inadequate sewage and wastewater treatment facilities, and other chemical pollutions. Infectious diseases caused by climate change, sea-level rise, soil degradation, and spread of infection through animals are also increasing throughout Asia \[[@B4-ijerph-17-04617]\]. As such, people living in Asian countries are facing health problems and risks due to the influence of worsening air, water, and soil quality. The extent of these problems, however, depends on the individual countries' geographic, economic, and cultural characteristics \[[@B5-ijerph-17-04617]\].

Governments set the investment directions for healthcare and welfare systems through policies and regulations. Such policies and regulations have consequences at both national and societal levels. Investing in healthcare and welfare systems is not only aimed at saving lives but it is also an important investment for the national economy \[[@B6-ijerph-17-04617]\]. This is because a healthy population and a well-designed welfare system can improve the productivity of the human capital, which can have a positive impact on national competitiveness \[[@B7-ijerph-17-04617]\]. As the budget for healthcare and welfare investments are usually constrained within the government's overall budget system, an investigation of the efficiency of investments in healthcare and welfare is essential \[[@B8-ijerph-17-04617]\]. It should be noted that, strictly speaking, healthcare and welfare policies would be different from each other. However, the "healthcare and welfare" terms are generally used together since healthcare and welfare variables are related to each other and integrated. As a result, treating them separately might lead to difficulties in evaluating the effects of these policies.

Against this background, this study evaluates the characteristics and effectiveness of national healthcare and welfare policies in 34 developing countries in Asia using dynamic data envelopment analysis (DEA) techniques. The healthcare and welfare policies of developed, developing, and least-developed countries in the world possess different characteristics. The share of investment in healthcare also varies from country to country \[[@B9-ijerph-17-04617],[@B10-ijerph-17-04617]\]. The share of investment in healthcare and welfare has been increasing worldwide in line with the "Millennium Development Goals (MDGs)" and "Sustainable Development Goals (SDGs)". Nevertheless, there are difficulties in evaluating the efficiency of such investments due to different economic development levels, different external environments, and domestic policy differences in each country \[[@B11-ijerph-17-04617]\]. Due to these factors, there are only a few studies in the literature that have employed consistent and comparable indicators across countries. Most of these studies focus on developed countries.

In order to assess and compare the efficiency of healthcare and welfare investments by different countries, it is first necessary to use compatible data on healthcare and welfare expenditures using the same standards for each country in the study \[[@B12-ijerph-17-04617]\]. There are five priority areas suggested by key health policy experts from the World Health Organization (WHO) and Non-Governmental Organizations (NGOs) \[[@B13-ijerph-17-04617]\]. The variables that cover these priority areas would form a compatible and comparable basis for cross-country comparisons on the efficiency of healthcare and welfare investments. These priority areas are the following:Universal Health CoveragePrimary Health CareHealth Systems StrengtheningHealth FinancingAccess to Medicines

In our study, the "Universal Health Coverage" and "Primary Health Care" indicators are associated with one of the input variables ("Current Health Expenditure (CHE) per Capita in PPP") in our two-stage DEA model. The "Health Systems Strengthening" category is the main goal of this study and it is linked to enhancing national competitiveness. The "Health Financing" category is related to investments and national healthcare and welfare policies as the second input variable in our TS-DEA model, proxied by "Domestic General Government Health Expenditure (GGHE-D) as % of Current Health Expenditure (CHE)". Finally, the priority area "Access to Medicines", is associated with an indicator such as healthcare personnel that includes physicians, pharmacists, nurses, and midwives and it is included in the intermediary stage of the analysis.

In addition, the efficiency comparisons on healthcare and welfare investments might also be sensitive to the methods used. There are a multitude of methods for measuring the characteristics and efficiency of healthcare and welfare policies by different countries \[[@B14-ijerph-17-04617]\]. One method that comes to the fore in the literature is the "Data Envelopment Analysis (DEA)" technique. Hence, we employ the dynamic DEA technique in this study.

Compared to previous studies that use data on investment expenditures in the healthcare and welfare sectors only \[[@B15-ijerph-17-04617]\], our study employs a broader range of data on healthcare and welfare expenditures and more detailed national health indicators. We include the incidence of tuberculosis, life expectancy, and under-five mortality rates in our study, in addition to the conventional data on healthcare and welfare expenditures. As such, our study is designed to be more comprehensive in comparing the efficiency of the healthcare and welfare policies of the countries in our sample. Earlier studies argued that as real GDP increases, a country invests more in healthcare and welfare programs and conducts more elaborated healthcare policies \[[@B16-ijerph-17-04617]\]. However, in terms of efficiency, a higher economic development level does not necessarily bring about more efficient healthcare policies \[[@B17-ijerph-17-04617]\]. Therefore, the importance of having systematic healthcare and welfare policies/programs under limited financial and physical resources is emphasized \[[@B18-ijerph-17-04617]\]. Our paper stresses the need for continuous study on the utility of such investments in the healthcare sector in each country and highlights the need for collaboration between all the stakeholders involved, which is related to both efficiency and cost/benefit perspectives. Both the methodology and the operationalization of input and output variables are different than earlier studies in the literature, providing a new perspective on measuring the efficiency of healthcare and welfare investments. Despite the importance and urgency of the topic for Asian countries, the literature lacks comprehensive and consistent studies in healthcare and welfare investment efficiency evaluation for developing Asian countries. Our study hopes to help fill this gap.

The rest of the paper is organized as follows. In [Section 2](#sec2-ijerph-17-04617){ref-type="sec"}, we provide the theoretical background and the characteristics and efficiency of healthcare and welfare policy and review the literature. In [Section 3](#sec3-ijerph-17-04617){ref-type="sec"}, we discuss the research design and the methodology. We use the two-stage DEA technique, which provides a more dynamic analysis framework for the variables in the model compared to the conventional static DEA approach. The data used in this study are obtained from public data sources such as the World Health Organization (WHO), the United Nations (UN), and the World Bank (WB). In [Section 4](#sec4-ijerph-17-04617){ref-type="sec"}, we present and discuss our findings. [Section 5](#sec5-ijerph-17-04617){ref-type="sec"} discusses the policy implications of our results and concludes the paper. Finally, in [Section 6](#sec6-ijerph-17-04617){ref-type="sec"}, we acknowledge some shortcomings of the study due to data availability constraints and suggest directions for future research in the field.

2. Review of Literature and Latest Trends {#sec2-ijerph-17-04617}
=========================================

2.1. Literature Review {#sec2dot1-ijerph-17-04617}
----------------------

The literature on the efficiency of the public sector focuses on public sector performance (PSP) and public sector efficiency (PSE). In this section, we discuss in more detail the general findings in the literature that suggest a further potential for increasing the efficiency of public sector investments. However, the results in the literature are rather broad in scope and not specific to healthcare and welfare sector investments. In earlier studies, only an index of public expenditures on healthcare was used as a comparison indicator in the healthcare sector. A more accurate assessment of the efficiency of investments in healthcare and welfare sectors requires the use of more specific and detailed (sub-) indicators \[[@B19-ijerph-17-04617]\].

Afonso et al. (2005) employed the non-parametric frontier production function approach using a composite index and seven sub-indices to examine input and output efficiencies of public healthcare spending in 23 OECD countries. The findings indicated the existence of large differences in the public sector performance (PSP) and public sector efficiency (PSE) across the countries in the sample, suggesting an important potential for expenditure savings in many countries. It should be noted that an increase in private healthcare spending does not necessarily bring about improvements in the public finance and healthcare system. A more systematic approach is needed to enhance the sustainable healthcare structure from a national perspective \[[@B20-ijerph-17-04617]\]. In addition to the public healthcare sector, comparative studies on the efficiency of public and private hospitals have been conducted. Jing et al. (2020) used data envelopment analysis (DEA) and propensity score matching (PSM) to measure the technical efficiency. This study suggested that public hospitals should strive to improve standards of management and focus on the structure management of human capital in hospitals such as health care providers as well as cost reduction of hospitalization. In addition, private hospitals are recommended to expand in size through an appropriate restructuring \[[@B21-ijerph-17-04617]\].

Spinks and Hollingsworth (2009) provide a cross-country comparison of technical efficiency in health production using health expenditure data and socioeconomic indexes such as education, employment, and GDP per capita as input variables. The output variable is chosen as life expectancy (in years) at birth. The study has limitations in comparing healthcare production efficiency in a broader setting of input and output variables \[[@B22-ijerph-17-04617]\]. Further studies in the literature include Evans (2001) and Woolcock (2018). Evans (2001) estimated the efficiency of a national health system in 191 countries using the health expenditure index as an input variable \[[@B23-ijerph-17-04617]\]. Woolcock (2018) also compared the relationship between gross national income per capita and disability-adjusted life years (DALY) in developing countries \[[@B24-ijerph-17-04617]\].

As reviewed above, the limited number of earlier studies in the literature on national healthcare and welfare policy efficiency used a traditional input variable such as health expenditure and did not characterize output with a variety of variables that capture different aspects of healthcare and welfare policies. In addition, from a methodological perspective, there has not been many studies that include a dynamic time frame concept. These limitations lead to difficulties in comparing the changes in efficiency overtime, which is an important aspect in policy decision-making and policy/program evaluation. A systematic evaluation of the changes in the efficiency of investments is an important dimension in establishing national healthcare policies, implementing the relevant strategies, and validating the achievement of national objectives in these areas.

2.2. Latest Trends in Health and Welfare Policy {#sec2dot2-ijerph-17-04617}
-----------------------------------------------

The G20 Summit, launched in 2008, includes 20 major countries of the world based on the size of their economies. The Health and Finance Ministers' Meeting under the G20 Summits began in 2017. In June 2019, the leaders at the G20 summit in Japan acknowledged that cooperation between health and financial authorities could be a driving force for improving the efficiency of health finance in developing countries. A testimony is made for the fact that the healthcare policy is closely related to a country's limited financial situation. The meeting featured a key agenda on achieving sustainable economic growth through universal health coverage in developing countries. The detailed agenda includes (1) commitment of the Minister of Health and Finance with understanding on the importance of Universal Health Coverage (UHC) financing in developing countries, (2) a description of proposals and best practices for cooperation with health and financial authorities, and (3) suggestions for strengthening cooperation between the World Health Organization (WHO) and World Bank (WB) \[[@B25-ijerph-17-04617]\]. Since the establishment of a quality and sustainable health care system depends on both health and financial authorities of each country, it should be recognized that it is important to create a policy framework for sustainable cooperation in the design process and procurement of health care systems.

To date, there has been a continued interest in cross-national comparisons of health systems and policies between policy analysts and policymakers. Research in the field of healthcare and welfare has expanded over time, but a systematic assessment of the quality of these studies received less interest. Perhaps the concept of "quality" itself is multi-dimensional and can vary from environment to environment. There have been assessment tools for some of these studies or methods, but they are not designed for cross-country comparisons of health systems and policies. Research on health systems and policies also suggests that differences in methodological approaches might be important for the results obtained \[[@B26-ijerph-17-04617]\].

Every country recognizes the importance of its healthcare and welfare systems/programs, and thus investment in these areas continues to increase: Improving the health and welfare of the people is a key national policy objective. This is a challenge for most OECD countries, along with the growing proportion of government debt, when viewed in conjunction with the financial sectors of the OECD countries' economic and financial crises. In particular, the 2010 OECD report suggests that public spending on healthcare is one of the largest government spending items, with an average of 6% of GDP. The increasing costs associated with the healthcare sector correlates with the aging of populations and the development of medical technology \[[@B27-ijerph-17-04617]\]. Some studies project national health expenditures to account for up to 19.4% of GDP by 2027 \[[@B28-ijerph-17-04617]\].

Therefore, improving efficiency is essential to meet rapidly increasing medical needs and to maintain investment and systems while determining the operation and direction of public finances in these health and welfare sectors \[[@B29-ijerph-17-04617]\]. The question is what should be done to improve the efficiency of healthcare and welfare sectors? One option is to use a comparative perspective and examine the performance of various healthcare and welfare systems with reference to their strengths and weaknesses. Such country-specific comparisons could lead to policies that could improve the effectiveness of overall healthcare and welfare systems. This is also contingent on the maintenance of good indicators and improvements made in each country's health care systems.

Trends in the Asia-Pacific (AP) region show that, in recent years, we have been intensively investing in the areas of health infrastructure, health governance, and health financing. In particular, the Asian Development Bank (ADB) announced its "Health 2015--2020 Operation Plan" in June 2015, which suggested the initiation of strategic investments in developing countries in the areas of health-related infrastructure, health governance, and health financing to improve Universal Health Coverage. In particular, the ADB is expanding its public and private health services through its "Operational Plan for Health (OPH)", in collaboration with the United Nations (UN).

Similarly, improving the outcome efficiency for health sector investments in the Asia-Pacific (AP) region is an important policy objective along with increasing investments in integrated and cost-effective programs. The objectives include the improvement and expansion of healthcare in low- and lower-middle income countries, strengthening new and innovative ways in current policies, and ensuring the quality health care that maintains efficiency and cost-effectiveness \[[@B30-ijerph-17-04617]\].

The current trends and developments on the characteristics and policies of the healthcare and welfare sector in the Asia-Pacific region and around the world point to a great deal of interest for efficient use of investments in healthcare and welfare areas, and this necessitates a systematic analysis of the policy and program outcomes at the national level. This study aims to contribute to the literature by assessing the changes in the efficiency of healthcare and welfare investments in 34 Asian developing countries between 2002 and 2016. Most of the countries in our study are classified as low- or lower-middle income countries, with the exception of some oil-producing countries in the Middle East.

3. Materials and Methods {#sec3-ijerph-17-04617}
========================

3.1. The Two-Stage DEA Approach {#sec3dot1-ijerph-17-04617}
-------------------------------

The concept of efficiency is used for evaluating the outputs or outcomes that result from the use of resources in the performance of an organization or country to accomplish its objectives \[[@B31-ijerph-17-04617]\]. Efficiency means "the ratio of output to input" \[[@B32-ijerph-17-04617],[@B33-ijerph-17-04617]\]. To measure efficiency in the healthcare and welfare investments, this paper uses the DEA analytical method that was first proposed by Charnes, Cooper, and Rhodes (1978) \[[@B34-ijerph-17-04617]\].

DEA is a non-parametric approach based on linear programming, with the Charnes, Cooper, and Rhodes (1978) model (CCR) that assumes constant returns to scale (CRS) \[[@B34-ijerph-17-04617]\], and the BCC model which deals with variable returns to scale (VRS) proposed by Banker et al. (1984) \[[@B35-ijerph-17-04617]\]. In this study, we perform an output-oriented DEA analysis that maximizes the level of output elements while maintaining the level of inputs. The output-oriented DEA model is useful in the efficiency evaluation of port, steel, and automobile industries where the input factor is large fixed capital goods \[[@B36-ijerph-17-04617]\]. We use the output-oriented DEA analysis in this study because of the large nature of the capital requirements in the healthcare and welfare areas.

On the other hand, the traditional DEA model measures the relative efficiency of each decision-making unit (DMU) with multiple inputs and multiple outputs. However, the process by which input elements are converted to output elements is not clearly explained. This is an advantage of the existing DEA model, but also limits the application of the DEA model in various areas. The Network DEA model was introduced by Färe and Grosskopf (2007) \[[@B37-ijerph-17-04617]\]. They first referred to the "black box" and focused on the conversion process inside the black box. They pointed out that the input DEA model was measured in the black box as an output element through a conversion process, and the actual conversion process has not been clearly explained. Therefore, they generalized the network model by focusing on the conversion process of the black box \[[@B38-ijerph-17-04617]\]. Tone and Tsutsui (2009) also identified the need for a new DEA model because a traditional DEA model could not belong to input and output simultaneously, since all activities can only belong to either input or output \[[@B39-ijerph-17-04617]\]. The following is the mathematical process used to analyze the two-stage DEA research model, as shown in [Figure 1](#ijerph-17-04617-f001){ref-type="fig"}.

If we let $v_{i}$ denote the multiplier associated with input *i* (*I* = 1, 2, 3), $u_{r}$ denote the multiplier associated with output *r* (*r* = 1, 2, 3), and $w_{g}$ denote the multiplier associated with intermediate product *g* (*g* = 1, 2, 3), then, when calculating the system efficiency of decision making unit ${(DMU)}_{k}$, each process must comply with the frontier condition in that the aggregated output must be less than the aggregated input, which is the additional condition to the conventional constraints for the system. $$E_{k} = max~u_{1}Y_{1k} + u_{2}Y_{2k} + u_{3}Y_{3k}$$ $$v_{1}X_{1k} + v_{2}X_{2k} + v_{3}X_{3k} = 1$$ $$(u_{1}Y_{1j} + u_{2}Y_{2j} + u_{3}Y_{3k}) - \left( {v_{1}X_{1j} + v_{2}X_{2j} + v_{3}X_{3k}} \right) \leq 0,~j = 1,\ldots,n$$ $$\left( {w_{1}Z_{1j} + w_{2}Z_{2j} + w_{3}Z_{3j}} \right) - \left( {v_{1}X_{1j} + v_{2}X_{2j} + v_{3}X_{3j}} \right) \leq 0,~j = 1,\ldots,n$$ $$(u_{1}Y_{1j} + u_{2}Y_{2j} + u_{3}Y_{3k}) - \left( {w_{1}Z_{1j} + w_{2}Z_{2j} + w_{3}Z_{3j}} \right) \leq 0,~j = 1,\ldots,$$ $$u_{1},u_{2},u_{3},u_{4},~v_{1},v_{2},v_{3},v_{4},w_{1} \leq \mathsf{\varepsilon}$$

Constraint (3) conforms to the system and constraints (4) and (5) conform to the two sub-processes of the system, respectively. The additional constraints from the processes induce the relational Network DEA model stricter than the traditional DEA model. Once the optimal multipliers v_i, u_r, and w_g are calculated from the models above, the efficiencies of the three processes are obtained as:$$E_{k}^{(1)} = \left( {w_{1}Z_{1j} + w_{2}Z_{2j} + w_{3}Z_{3j}} \right)/\left( {v_{1}X_{1j} + v_{2}X_{2j} + v_{3}X_{3j}} \right)$$ $$\left. E_{k}^{(2)} = (u_{1}Y_{1j} + u_{2}Y_{2j} + u_{3}Y_{3k})/(w_{1}Z_{1j} + w_{2}Z_{2j} + w_{3}Z_{3j} \right)$$ $$\left. E_{k}^{(3)} = (u_{1}Y_{1j} + u_{2}Y_{2j} + u_{3}Y_{3k})/(v_{1}X_{1j} + v_{2}X_{2j} + v_{3}X_{3j} \right)$$

Thus, $E_{k}^{(1)}$ is used to calculate the efficiency of the first stage, $E_{k}^{(2)}$ is used for the second stage, and $E_{k}^{(3)}$ is used for the third stage.

3.2. Research Model and the Operationalization of Input, Intermediary, and Output Variables {#sec3dot2-ijerph-17-04617}
-------------------------------------------------------------------------------------------

Each variable in the model consists of relevant indicators obtained from public data sources, such as the World Health Organization (WHO), United Nations (UN), and World Bank (WB). In choosing the indicators to reflect the characteristics and efficiency of health and welfare policies in the countries in our sample, we have considered those that are most relevant and available for as many countries as possible. This approach is in line with earlier studies \[[@B40-ijerph-17-04617],[@B41-ijerph-17-04617]\]. First, "Health Expenditure" indicators for the input variable included "Current Health Expenditure (CHE) per Capita in PPP", which are most commonly used indicators in the assessment of the health and welfare sector. "Domestic General Government Health Expenditure (GGHE-D) as % of Current Health Expenditure (CHE)" and "Current Health Expenditure (CHE) as % of Gross Domestic Product (GDP)" were also included as measures of the government's share of public investments in GDP.

The second category was intermediary, which included indicators that were related to healthcare providers: Health personnel (physicians (per 1000 population)), (pharmacists (per 1000 population)), and (nurse and midwife personnel (per 1000 population)). Health personnel is important and requires management and training because as the national or government health expenditure increases, the number and proportion of healthcare professionals will increase. The third category was output, which included the incidence of tuberculosis (per 100,000 people), mortality rate, under-five (per 1000 live births), and life expectancy at birth, total (years). In particular, those indicators that are related to the output were selected because they can be used to compare the competitiveness of each country in the health, welfare, and medical sectors. For example, the incidence of the tuberculosis index has been rarely used in the research field of health and welfare, but it was judged to be useful in comparing the health infrastructural power of developing and developed countries. Similarly, the mortality rate and mortality under-five rates are comparable indicators of national competitiveness, and life expectancy at birth and total (years) are commonly used in the literature \[[@B42-ijerph-17-04617]\]. Therefore, to compare with the other two indicators, they can be used as complementary indicators. [Figure 2](#ijerph-17-04617-f002){ref-type="fig"} shows the structure and the variables of our model that will be used as the basis for the DEA analysis.

4. Results {#sec4-ijerph-17-04617}
==========

This section presents the empirical implementation of the two-stage dynamic DEA approach using the theoretical model framework described in [Section 3](#sec3-ijerph-17-04617){ref-type="sec"} and the calculation of relevant input, intermediary, and output variables, as shown in [Figure 2](#ijerph-17-04617-f002){ref-type="fig"}. Our study includes 34 developing countries in Asia and assesses the efficiency of their healthcare and welfare investments for the time period between 2002 and 2016. The list of the countries and the data used in the analyses are included in the [Appendix A](#app1-ijerph-17-04617){ref-type="app"}.

We divide the data into three time frames and apply a three-years' time lag as suggested by the results of previous DEA studies that have revealed that it takes about three years to derive results when any input is entered \[[@B43-ijerph-17-04617]\]. The first time frame is set as 2002\~2004 for input 1, 2, 3, and 2005--2007 for intermediary 1, 2, 3, and 2008--2010 for output 1, 2, 3. The second time frame is set as 2005--2007 for input 1, 2, 3, and 2008--2010 for intermediary 1, 2, 3, and 2011--2013 for output 1, 2, 3. The third time frame is set as 2008--2010 for input 1, 2, 3, and 2011--2013 for intermediary 1, 2, 3, and 2014--2016 for output 1, 2, 3. Moreover, due to the nature of healthcare policies, the budget for medical care is more likely to be executed in a particular year than in other years. Hence, we used three-years' average values for each variable. For example, "input 1" variable uses the average value from 2002 to 2004, "intermediary 1" variable uses the average value from 2005 to 2007, and "output 1" variable uses the average value from 2008 to 2010. [Table 1](#ijerph-17-04617-t001){ref-type="table"} shows the organization of the data and the time frames using the example of Afghanistan. The same structure is used for all other countries in our study.

As it can be seen in [Table 1](#ijerph-17-04617-t001){ref-type="table"}, in Afghanistan, for example, three input variables corresponding to 2002--2004 were the input from TF_1 (Afghanistan1), and the efficiency values for three intermediary variables corresponding to 2005--2007 were measured. Efficiency values for three output variables (2008--2010) were measured from three intermediary variables (2005--2007). Similarly, the efficiency values of the three output variables (2008--2010) were also measured from the three input variables (2002--2004). Therefore, a total of three analyses was conducted on TF_1 for Afghanistan1. Since each of the three analyses was conducted for TF_2 (Afghanistan2) and TF_3 (Afghanistan 3), Afghanistan is calculated to have a total of nine analyses. As a result, since the efficiency analysis was conducted for a total of 34 countries, the total number of analyses in this study is 306 by multiplying 9 in 34 countries.

Our study includes the results of efficiency analysis across a total of three routes using the two-stage DEAs. The first analysis was the efficiency analysis for input intermediary, which corresponded to the Health Investment Efficiency (HIE). The input and intermediary were each composed of three variables. The second analysis was intermediary → output, which corresponded to the Health Competitiveness Efficiency (HCE), also each composed of three variables. The third analysis was conducted by the direct route of input → output to see the efficiency result of the overall investment, which was referred to as Overall Efficiency (OE).

[Table 2](#ijerph-17-04617-t002){ref-type="table"} shows the average efficiency of healthcare and welfare investments in 34 Asian countries in our study.

[Table 2](#ijerph-17-04617-t002){ref-type="table"} shows the mean values for the analysis results of 34 countries in three routes analysis. According to the results for each stage, the efficiency analysis result of Stage 1 corresponding to the Health Investment Efficiency (HIE) showed 0.399, and the efficiency analysis result of Stage 2 corresponding to the Health Competitiveness Efficiency (HCE) showed 0.612. Finally, the efficiency analysis result of Stage 3, which corresponds to the Overall Efficiency (OE), was 0.669, which showed the highest efficiency result among the three routes in terms of relative efficiency results. It should be noted that the estimated efficiency scores are in relative terms. Therefore, they should not be interpreted as absolute numbers in levels. Nevertheless, the closer they are to one, the higher is the relative efficiency compared to the other countries in the sample.

In [Table 2](#ijerph-17-04617-t002){ref-type="table"}, the value of the efficiency of Stage 2 is found to be relatively higher than Stage 1, which means that it takes more time and effort to establish the indicator related to healthcare providers in the intermediary from the input. On the other hand, Stage 2 shows that the intermediary variables of healthcare providers are more generally efficient in increasing the efficiency of output variables. Therefore, it is important to invest in the intermediary variable itself, but if the healthcare professionals and related industries, and medical technologies are developed together, the indicators of the "Health Care Indicators" corresponding to the output efficiency will be improved further.

[Table 3](#ijerph-17-04617-t003){ref-type="table"} shows how the raw data values of each indicator in terms of time frames have changed as "time frame 1" → "time frame 2" → "time frame 3" progressively. [Table 3](#ijerph-17-04617-t003){ref-type="table"} displays 34 countries' average scores of input, intermediary, and output raw data by time frames. For example, the three indicators of output were gradually improving toward period_1 (2008--2010), period_2 (2011--2013), and period_3 (2014--2016). By indicator, first, "output 1" corresponding to an incidence of tuberculosis indicated that the incidence gradually decreased from period_1 (503.547), to period_2 (477.818), and to period_3 (453.024). Second, the "output 2" corresponding to the mortality rate, under-five showed that the mortality rate decreased from period_1 (110.600), to period_2 (96.715), and to period_3 (86.203). Third, "output 3", which corresponds to life expectancy at birth, total (years), indicates that life expectancy increased from period_1 (70.098), to period_2 (70.851), and to period_3 (71.564). It is observed that some indicators in the input and intermediary do not increase proportionally to the time frame. Nevertheless, it is important to note that this may be attributed to various factors such as lack of sustained investments or lack of policy consistency in individual countries. Hence, it can be expected that the output efficiency may vary depending on the investment by item in accordance with national policy and may also change depending on the time frame.

[Table 4](#ijerph-17-04617-t004){ref-type="table"} shows the top 10 countries with the highest values and bottom 10 countries that had the lowest values. Full results for all 34 countries are included in the [Appendix A](#app1-ijerph-17-04617){ref-type="app"} [Table A1](#ijerph-17-04617-t0A1){ref-type="table"}, [Table A2](#ijerph-17-04617-t0A2){ref-type="table"}, [Table A3](#ijerph-17-04617-t0A3){ref-type="table"} and [Table A4](#ijerph-17-04617-t0A4){ref-type="table"}.

The efficiency scores were computed for three categories: Health Investment Efficiency (HIE), Health Competitiveness Efficiency (HCE), and Overall Efficiency (OE). Of the top ten scores for the highest "Health Investment Efficiency (HIE)" indicators, Kazakhstan3 (1.000000), India2 (1.000000), Kazakhstan2 (0.932438), and Azerbaijan2 (0.916659) show a relatively high efficiency. However, the efficiency scores of "Health Competitiveness Efficiency (HCE)" indicators for these four countries were overall low compared to the relatively high efficiency indicators of the "Health Investment Efficiency (HIE)", and all four countries were in the bottom 10: Kazakhstan3 (0.141866), India2 (0.205447), Kazakhstan2 (0.167765), Azerbaijan2 (0.191514). This means that the efficiency indicators for the results of an intermediary for the given input are good, but the results of output for a given intermediary is relatively low.

As seen above, the differences with the other 34 countries were analyzed and compared based on the results of the high efficiency of Kazakhstan3, India2, Kazakhstan2, and Azerbaijan2 in the Health Investment Efficiency (HIE) sector.

[Table 5](#ijerph-17-04617-t005){ref-type="table"} presents the results of a comparative analysis of the differences in these efficiency values.

Kazakhstan3 has higher investment indicators for "input 1" and "input 2" compared to the average of 34 countries. Intermediary indicators after three years show that the differences are more than ten times higher, indicating that the efficiency index of "Health Investment Efficiency (HIE)" is the highest. In particular, in Kazakhstan3, the value of the "Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE)" indicator, which corresponds to the "input 2" indicators, is 72.526, which is 74% higher than the average of 41.574 in the 34 countries. Thus, increasing weight in the government health expenditure sector is important for enhancing the "Health Investment Efficiency (HIE)" efficiency.

In terms of "Health Competitiveness Efficiency (HCE)", "output 3" of Kazakhstan3 is similar to the average value of 34 countries, and "output 1" and "output 2" are 50% lower than the average of 34 countries, showing relatively superior performance. For reference, the indicators of "output 1" and "output 2" show the incidence of tuberculosis (per 100,000 people), mortality rate under-five (per 1000 live births), respectively. In contrast, we have seen that the efficiency in the "Health Competitiveness Efficiency (HCE)" of Kazakhstan3 (0.141866) is relatively low in [Table 4](#ijerph-17-04617-t004){ref-type="table"} although the output indicators are superior to other countries in [Table 5](#ijerph-17-04617-t005){ref-type="table"}. The low "Health Competitiveness Efficiency (HCE)" may be because the number of "Health Care Providers" in the intermediary is more than adequate compared to the average of 34 countries. It could also be interpreted as a lack of competitive healthcare providers or inefficient healthcare settings and policies. It also suggests that it would be due to the differences in healthcare policies, and not just by healthcare providers, but also hospitals, systems, and the establishment of an efficient environment that are important items. As a reference, Kazakhstan has established policies that deviated from the former Soviet Union era in the 2000s. In particular, from 2005 to 2010, the country carried out national projects for the reorganization and development of the healthcare and welfare sector. Since 2010, many investments have been undertaken, focusing on improving the full-scale investment in the health and welfare policy and the expansion of medical benefits, while still striving to resolve health development and regional imbalances. There was an emphasis on developing new clinical guidelines \[[@B44-ijerph-17-04617]\].

Furthermore, since the 2000s, the Kazakhstan government has promoted the modernization of the healthcare sector by introducing the latest medical equipment or replacing clinic facilities with the help of a World Bank loan. More than 80% of Kazakhstan's hospitals and health care institutions are state-owned, and in 2009, the country drafted health laws that meet international standards, with the intention of joining the WTO \[[@B45-ijerph-17-04617]\]. These investments in the healthcare and welfare sectors, as a result, show that the indicators of "intermediary 1", "intermediary 2", and "intermediary 3" corresponding to Kazakhstan3 are 10 times higher than the average of 34 countries. In addition to investing in the "Health Care Personnel", there is also a focus on country-specific collaboration through MOUs such as health policies and systems, new medical technologies and devices, e-health, pharmaceutical industry, networks, and professional exchanges. Thus, if the skills and competitiveness in the "Health Care Personnel" field are increased through such continuous investments and collaborations, the efficiency indicator value for the "Health Competitiveness Efficiency (HCE)" may be improved. Above all, it is important to recognize the areas that need improvement as the example of Kazakhstan shows and implement policies from various perspectives to address the shortcomings and the inefficiencies.

In India2, indicators of "input 1" and "input 2" account for only 29% and 53%, respectively, which are relatively lower than the average for 34 countries. There is a potential for increasing investments in health expenditure, public health, and expanding the health care system. Additionally, the "output 1" and "output 2" indicators were 703.000 (147%) and 157.200 (163%), respectively, higher than the average of 34 countries. Unlike Kazakhstan3, it is important for India2 to establish a policy focusing on lowering the incidence of tuberculosis and under-five mortality rate.

India's economy is already a global powerhouse and the industry is growing fast, but its health service sector performance is lower than average and vulnerable. For example, the top ten causes of death in India include premature birth complications, which are not highlighted in the OECD, but a major issue in India and in other low- and lower-middle income countries in Asia. As a result, India continues to draw attention and investment in insurance benefits which are being implemented through projects at a national level, which is one of the most important areas in terms of income and job creation in a country with a population of more than 1.3 billion.

In this context, the major initiatives taken by the government of India to push forward the Indian health care industry are as follows. The government of India launched Pradhan Mantri Jan Arogya Yojana (PMJAY) in 2018 to provide national health insurance of over 500,000 Rs (USD 7124) to more than 100 million families each year. In addition, India started Mission Indradhanush to improve the countries' immunization coverage. It aims to achieve at least 90% vaccination coverage by 2018 \[[@B46-ijerph-17-04617]\].

The countries such as Kazakhstan3, India2, Kazakhstan3, and Azerbaijan2 included in the top 10 countries in [Table 4](#ijerph-17-04617-t004){ref-type="table"} show higher levels of "Health Investment Efficiency (HIE)", but in terms of "Health Competitiveness Efficiency (HCE)", they show lower scores and are included in the bottom 10 countries. This can be interpreted as the environment, systems, and policies related to health care providers are inefficient or not managed properly. In this regard, it is necessary to increase the efficiency of the overall health and welfare policy by aiming to improve output indicators more directly. For example, Azerbaijan imports 98% of its medicines from other countries despite the high morbidity rate. Therefore, it will be necessary to invest in the healthcare and welfare systems of the economy \[[@B47-ijerph-17-04617]\]. In addition, relatively low levels of government expenditure on health as a proportion of the gross domestic product since independence has meant that out of pocket (OOP) payments accounted for almost 62% of total health expenditure in 2007. This has serious implications for access to care and financial risk \[[@B48-ijerph-17-04617]\].

Indonesia also shows relatively good efficiency indicators. [Table 6](#ijerph-17-04617-t006){ref-type="table"} presents the detailed results on Indonesia.

It is significant that all three time frames for Indonesia are included among the Top 10 of Overall Efficiency (OE) results with Indonesia1 (0.977166), Indonesia2 (0.946518), and Indonesia3 (0.945692). The average value of variables corresponding to the inputs and outputs of Indonesia1, Indonesia2, and Indonesia3 indicate that most of the variables gradually increased or showed improved indicator values over time. These results can be inferred from the systematic and consistent investment in the healthcare sector in Indonesia and improved operationalization of the policy in the health and welfare sectors. However, investment in the "Domestic General Government Health Expenditure (GGHE-D)", which corresponds to "input 2", is still relatively lower than the average of 34 countries (32.471 vs. 39.773); hence, an increased focus on this area can further improve efficiency.

In contrast, countries with relatively low efficiency outcomes include Kuwait, Jordan, Maldives, Turkmenistan, and Afghanistan ([Table 7](#ijerph-17-04617-t007){ref-type="table"}). In particular, Kuwait showed relatively low efficiency values not only in "Overall Efficiency (OE)" but also in "Health Investment Efficiency (HIE)", and "Health Competitiveness Efficiency (HCE)".

The raw data values for Kuwait show that the "Current Health Expenditure (CHE)" value corresponding to "input 1" was about five to six times higher than the average of 34 countries, and the "Domestic General Government Health Expenditure (GGHE-D)" equivalent to "input 2" was also about two times higher. Therefore, Kuwait is showing generally low efficiency even though it spends a considerable amount of money on healthcare and makes relatively high investments in the public sector ([Table 7](#ijerph-17-04617-t007){ref-type="table"}). To improve these inefficiencies for Kuwait, the government should focus on improving the overall health care system and aim to increase the overall efficiency at the national level, keeping pace with consistent policies such as increasing the share of health insurance benefits. One suggestion is that Kuwait needs to have a competitive healthcare infrastructure through investments in human resources such as healthcare providers, technologies and investments in hospitals, and overall medical infrastructure.

Average levels of investments in health and welfare and the average levels of public health indicators in Asian economies are still low in a global comparison. The results on the measurement of relative efficiency in healthcare and welfare sectors of 34 Asian developing countries in our study identify key areas and indicators that need improvement in each country. Most importantly, it is essential to consistently invest in these areas and indicators with national and governmental goals. Benchmarking with more efficient countries' indicators will also help in guiding the policies and programs in healthcare and welfare areas.

Asian developing countries are in a different situation than developed economies. Economic development indicators such as GDP are still growing at high rates in Asia and the health and medical industries are also growing in line with overall economic growth. Hence, the policy direction should be somewhat different in Asian developing countries compared to developed economies, e.g., OECD countries. It will be necessary to increase the efficiency of national healthcare and welfare policies by establishing relevant policies that are tailored to the current economic situation, characteristics, and external environments of the countries in question.

5. Conclusions {#sec5-ijerph-17-04617}
==============

This study analyzes the characteristics and efficiency of the healthcare industry in 34 Asian countries by means of the two-stage DEA model derived from the existing traditional DEA model. Previous studies in the literature analyzed the efficiency through multi-output at multi-input models. Our two-stage DEA model includes input, intermediary, and output layers capturing the direction and the nature of the national healthcare and welfare policies in each country. The input, intermediary, and output layers are related to each other. This approach enables the results obtained to provide more specific and practical representation of the efficiency characteristics and changes in them overtime. Moreover, it is a meaningful approach to compare countries' efficiency scores by time series, since it is a critical task for the country-level in the field of healthcare policy making. Countries need to consider how to supplement the policies and directions for the insufficient efficiency area. Therefore, complementation by comparison with other countries is essential, but it is also crucial to see how it fluctuated over time in the country itself.

As stated in the Introduction, the proposals and implementation of policies in healthcare and welfare areas constantly evolve globally as countries focus more attention on the healthcare industry to promote the health and welfare of their citizens. However, in the situation where an indicator setting and evaluation are needed to improve the results in terms of efficiency by focusing on each country's efforts and investments, a formal format for evaluating the system has been lacking until now. This study not only analyzes the characteristics and efficiencies of national health and welfare policies in individual countries, but also applies the basic raw data as variables that can be commonly used to make comparisons between countries around the world in the field of healthcare and welfare. Before data selection, we investigated the real world's essential indicators in the recent healthcare sector, which are currently being discussed globally and included related indicators for the analysis in this paper. The model employed in this study can be used as a basic framework for comparing the characteristics and efficiency analysis of the healthcare and welfare industry by country. The data sources are publicly available. At the national level, the data used in this study might be used to benchmark the strengths of other countries and to address the weakness of national policies and strengthen the policy-making process of the healthcare and welfare sectors. The methodological framework, the operationalization of different indicators of healthcare and welfare policies and their outcomes, and the findings of this study can be helpful in establishing future policies in the field of healthcare and welfare. The overall framework can play a major role in judging the efficiency of investments and identifying collaboration possibilities.

6. Limitations of the Study and Directions for Further Research {#sec6-ijerph-17-04617}
===============================================================

This study uses country-level data from 2002 to 2016 to analyze the characteristics and efficiency of national health and welfare policies. Some limitations exist in comparing the most recent policy data for 2019 because it usually takes lag to update common data for each country. Investment in the healthcare and welfare sectors continues to be made, and is a field of high interest in each country. Due to the nature of the efficiency analyses, the efficiency indicators in this study are only comparative values of relative efficiency. In other words, there is room for improvement even in countries with high efficiency indicators.

The variable set can also be expanded in future studies. Additional variables, such as "Primary Health Care (PHC) Expenditure per Capita" or "rate of national health insurance benefits" could be used in strategizing national policies as more and comparable cross-country data become available. In particular, the "Primary Health Care (PHC) Expenditure per Capita" category is a field that has attracted investments and interests all over the world and is one of the top priority areas for national health as part of chronic disease prevention projects. Many projects are necessary for the establishment and implementation of national policies in this area. Hence, an integrated approach to manage and prevent chronic diseases is essential in primary healthcare in low and middle-income countries \[[@B49-ijerph-17-04617]\]. Several clinical guidelines of medical societies also emphasize the importance of primary healthcare and prevention worldwide \[[@B50-ijerph-17-04617]\].

Currently, country-level data on "Primary Health Care (PHC) Expenditure per Capita" is not yet publicly available. When it becomes available, it would be an important additional insight to efficiency assessments of healthcare and welfare investments. The second potential variable to include in the model is the rate of national health insurance benefits. It may be used as an important indicator because it is also in line with the financial and economic conditions of the national health care sector. The addition of these two variables into the model will complement the results of previous studies that evaluate the relative achievements of national healthcare policy efficiency in individual countries.

Finally, although not directly linked to the healthcare and welfare sector, comparisons with sub-indicators such as the poverty headcount ratio at national poverty lines (% of the population) as indirect indicators will be meaningful in a more comprehensive and broader perspective. It may be used as a reference for the establishment and operation of healthcare and welfare policies. Overall, further studies on the subject would provide additional benchmarks in determining the direction of national policies.
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###### 

List of countries and the data used in the study (Time Frame_1).

  Country (TF_1)      Input 1    Input 2   Input 3   Int. 1   Int. 2   Int. 3   Output 1   Output 2   Output 3
  ------------------- ---------- --------- --------- -------- -------- -------- ---------- ---------- ----------
  Afghanistan1        248.347    4.569     9.398     0.000    0.000    0.600    567.000    281.800    60.741
  Armenia1            701.800    20.630    6.510     0.000    0.000    0.000    200.000    57.000     73.132
  Azerbaijan1         854.045    16.248    5.685     0.000    0.000    0.000    345.000    120.100    70.624
  Bahrain1            4108.647   64.707    3.772     1.100    0.200    2.800    86.000     26.700     75.913
  Bangladesh1         104.253    24.717    2.186     0.300    0.000    0.300    663.000    157.100    69.756
  Bhutan1             430.305    69.209    4.309     0.200    0.100    0.800    593.000    135.700    67.299
  Cambodia1           294.087    20.180    7.099     0.000    0.000    0.000    1351.000   144.400    65.985
  China1              513.337    28.001    4.328     0.000    0.300    1.000    242.000    51.300     75.025
  Georgia1            792.838    13.442    8.206     0.000    0.000    0.000    400.000    53.600     72.657
  India1              295.055    18.288    4.069     0.600    0.000    1.300    762.000    184.700    66.215
  Indonesia1          355.736    34.328    2.176     0.000    0.000    0.000    1036.000   104.300    67.963
  Iran1               1873.741   38.368    5.025     0.900    0.200    1.400    50.000     62.000     73.486
  Iraq1               536.726    58.131    3.417     0.000    0.000    0.000    137.000    113.300    68.308
  Jordan1             1879.090   44.436    9.265     2.400    1.300    3.300    19.600     65.100     73.250
  Kazakhstan1         1270.397   55.091    3.771     0.000    0.000    0.000    452.000    67.800     67.916
  Kuwait1             6305.675   79.894    3.188     0.000    0.000    0.000    113.000    33.200     73.870
  Lao P D Republic1   310.417    24.820    3.906     0.300    0.000    1.000    691.000    250.000    63.884
  Lebanon1            2645.785   34.626    8.573     0.000    1.000    1.200    43.000     32.500     78.161
  Malaysia1           1346.211   51.505    2.875     0.000    0.000    0.000    221.000    23.300     74.028
  Maldives1           1947.931   30.533    7.682     0.000    0.000    0.000    111.000    43.500     75.893
  Mongolia1           624.367    64.012    4.049     0.000    0.000    0.000    1284.000   86.700     66.917
  Myanmar1            109.810    11.581    2.087     0.400    0.000    0.700    1164.000   220.400    64.839
  Nepal1              182.395    17.746    4.502     0.000    0.000    0.000    491.000    149.100    67.478
  Oman1               3341.948   82.752    3.110     1.700    0.700    3.700    40.000     35.200     75.444
  Pakistan1           251.116    30.251    2.537     0.800    0.000    0.000    828.000    278.400    64.848
  Philippines1        343.168    36.327    3.031     0.000    0.000    0.000    1583.000   95.600     68.212
  Sri Lanka1          693.253    53.745    4.039     1.100    0.000    3.500    198.000    35.800     74.276
  Syria1              533.411    47.005    4.707     1.600    0.700    1.900    69.000     48.800     72.898
  Tajikistan1         177.446    17.742    4.646     2.000    0.000    0.000    424.000    134.900    69.279
  Thailand1           860.825    65.746    3.239     0.000    0.000    0.000    565.000    42.000     73.606
  Timor-Leste1        106.567    44.569    2.196     0.000    0.000    0.000    1494.000   196.000    66.914
  Turkmenistan1       1244.795   29.798    8.700     0.000    0.000    0.000    253.000    184.400    66.348
  Viet Nam1           368.783    45.034    4.683     0.600    0.300    0.800    478.000    69.600     74.947
  Yemen1              543.864    41.803    5.368     0.000    0.000    0.000    167.000    176.100    63.201

Input 1: Current Health Expenditure (CHE) per Capita in PPP. Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

List of countries and the data used in the study (Time Frame_2).

  Country (TF_2)      Input 1    Input 2   Input 3   Int. 1   Int. 2   Int. 3   Output 1   Output 2   Output 3
  ------------------- ---------- --------- --------- -------- -------- -------- ---------- ---------- ----------
  Afghanistan2        314.541    5.220     10.159    0.600    0.000    1.100    567.000    248.000    62.082
  Armenia2            1008.572   26.375    6.023     2.800    0.000    5.500    168.000    48.900     73.810
  Azerbaijan2         1655.464   15.706    5.954     3.600    0.200    8.000    289.000    98.000     71.465
  Bahrain2            3751.796   67.360    3.181     0.900    0.200    2.400    58.000     24.000     76.341
  Bangladesh2         139.884    22.718    2.328     0.400    0.400    0.200    663.000    130.900    71.032
  Bhutan2             516.182    61.450    4.114     0.200    0.100    1.000    572.000    114.600    68.635
  Cambodia2           348.524    17.756    5.958     0.200    0.000    0.900    1234.000   114.900    67.456
  China2              688.331    35.641    3.907     1.500    0.300    1.500    220.000    40.600     75.599
  Georgia2            1116.971   15.021    7.931     4.300    0.100    4.000    357.000    43.600     72.751
  India2              354.734    20.511    3.648     1.300    1.000    2.900    703.000    157.200    67.368
  Indonesia2          544.553    31.615    2.711     0.100    0.000    1.100    1005.000   91.800     68.508
  Iran2               2363.817   39.458    5.181     0.000    0.000    0.000    54.000     54.100     74.772
  Iraq2               880.057    67.247    2.809     0.600    0.200    0.000    135.000    105.200    68.961
  Jordan2             2113.986   53.230    8.407     2.500    1.400    3.900    15.800     59.600     73.728
  Kazakhstan2         1543.589   66.096    3.329     3.500    0.700    8.300    359.000    49.400     69.680
  Kuwait2             5915.978   79.862    2.255     4.300    0.300    11.100   71.000     29.900     74.217
  Lao P D Republic2   322.244    22.388    3.141     0.200    0.000    0.900    614.000    225.200    65.201
  Lebanon2            2899.019   40.178    8.248     2.700    1.300    2.000    42.000     28.200     78.855
  Malaysia2           1693.005   51.934    3.046     1.200    0.400    3.200    257.000    22.500     74.604
  Maldives2           2505.561   39.175    8.394     1.600    0.700    5.600    101.000    32.700     76.410
  Mongolia2           640.384    63.234    2.958     2.800    0.400    3.600    1284.000   67.600     68.198
  Myanmar2            152.565    9.717     1.893     0.500    0.000    0.900    1129.000   177.000    65.792
  Nepal2              200.941    20.478    4.246     0.000    0.000    0.000    482.000    127.500    68.729
  Oman2               2839.504   81.391    2.441     2.000    0.900    4.400    35.000     34.200     76.140
  Pakistan2           346.313    19.806    2.951     0.900    0.000    0.600    827.000    259.700    65.677
  Philippines2        536.247    32.169    3.922     0.000    0.000    0.000    1617.000   91.300     68.555
  Sri Lanka2          866.631    50.700    3.980     0.700    0.000    1.800    198.000    32.400     74.599
  Syria2              510.117    48.216    3.870     1.500    0.800    1.900    57.000     51.500     70.622
  Tajikistan2         259.446    19.010    5.261     1.700    0.000    4.500    325.000    118.700    70.223
  Thailand2           1045.564   73.400    3.151     0.400    0.100    2.100    518.000    36.300     74.440
  Timor-Leste2        189.592    32.457    1.143     0.100    0.100    1.200    1494.000   171.900    67.805
  Turkmenistan2       1492.071   21.913    7.752     2.300    0.200    4.800    207.000    167.300    67.157
  Viet Nam2           530.361    42.690    5.317     0.700    0.300    1.200    442.000    67.300     75.478
  Yemen2              634.132    29.354    5.519     0.300    0.100    0.700    146.000    166.300    64.041

Input 1: Current Health Expenditure (CHE) per Capita in PPP. Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

List of countries and the data used in the study (Time Frame_3).

  Country (TF_3)      Input 1    Input 2   Input 3   Int. 1   Int. 2   Int. 3   Output 1   Output 2   Output 3
  ------------------- ---------- --------- --------- -------- -------- -------- ---------- ---------- ----------
  Afghanistan3        403.725    5.671     9.548     0.000    0.000    0.000    567.000    219.500    63.285
  Armenia3            957.844    35.029    4.767     0.000    0.000    0.000    151.000    42.000     74.439
  Azerbaijan3         2122.185   22.803    4.765     0.000    0.000    0.000    213.000    79.400     71.916
  Bahrain3            4458.306   64.313    3.728     0.000    0.000    0.000    43.000     22.800     76.761
  Bangladesh3         176.008    20.907    2.415     0.000    0.000    0.000    663.000    109.300    72.149
  Bhutan3             555.947    71.676    3.412     0.000    0.000    0.000    503.000    100.200    69.815
  Cambodia3           503.836    17.096    7.032     0.000    0.000    0.000    1103.000   96.200     68.617
  China3              1033.435   48.609    4.136     0.000    0.000    0.000    198.000    32.400     76.092
  Georgia3            1632.930   20.385    9.354     0.000    0.000    0.000    297.000    36.300     73.103
  India3              418.386    24.815    3.424     0.000    0.000    0.000    651.000    132.400    68.294
  Indonesia3          656.242    31.469    2.753     0.200    0.000    1.400    976.000    81.800     69.024
  Iran3               3130.786   35.362    6.199     0.000    0.000    0.000    46.000     48.100     75.716
  Iraq3               1207.450   76.634    3.345     0.000    0.000    0.000    129.000    96.800     69.664
  Jordan3             2492.224   64.768    8.882     0.000    0.000    0.000    16.800     54.400     74.182
  Kazakhstan3         1723.213   72.526    3.085     3.500    0.800    8.500    243.000    36.100     71.973
  Kuwait3             6841.809   83.322    2.853     0.000    0.000    0.000    68.000     26.300     74.576
  Lao P D Republic3   380.943    24.131    3.047     0.000    0.000    0.000    546.000    203.600    66.331
  Lebanon3            3360.549   39.649    7.408     0.000    0.000    0.000    39.000     25.200     79.408
  Malaysia3           1976.736   53.838    3.211     0.000    0.000    0.000    272.000    22.800     75.140
  Maldives3           3527.119   55.478    10.017    0.000    0.000    0.000    134.000    26.400     77.055
  Mongolia3           821.199    64.319    3.036     2.900    0.500    3.700    1284.000   56.600     69.074
  Myanmar3            200.097    8.770     1.947     0.600    0.000    0.900    1095.000   157.300    66.454
  Nepal3              256.674    19.058    4.593     0.500    0.200    1.600    468.000    109.900    69.884
  Oman3               3337.708   80.948    2.529     0.000    0.000    0.000    28.000     33.700     76.803
  Pakistan3           337.860    20.994    2.711     0.000    0.000    0.000    808.000    238.500    66.314
  Philippines3        664.645    30.897    4.231     0.000    0.900    0.000    1650.000   87.300     68.953
  Sri Lanka3          1030.624   41.419    4.015     0.000    0.000    0.000    195.000    28.600     75.093
  Syria3              505.735    45.270    3.407     0.000    0.000    0.000    63.000     52.200     70.010
  Tajikistan3         345.461    20.756    5.834     0.000    0.000    0.000    262.000    107.400    70.873
  Thailand3           1313.525   76.641    3.490     0.000    0.000    0.000    490.000    31.400     75.100
  Timor-Leste3        301.595    48.003    1.371     0.100    0.100    1.200    1494.000   153.500    68.578
  Turkmenistan3       1419.288   21.443    5.238     0.000    0.000    0.000    153.000    151.500    67.697
  Viet Nam3           670.442    42.438    5.469     0.000    0.000    0.000    410.000    64.800     76.053
  Yemen3              707.985    24.068    5.636     0.000    0.000    0.000    144.000    166.200    64.740

Input 1: Current Health Expenditure (CHE) per Capita in PPP. Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

The efficiency estimates for all 34 countries (Time Frame_1, 2, 3).

  -----------------------------------------------------------------------------------------------------------------
  Country             HIE\_ Stage 1\                   HCE\_ Stage 2\                        OE\_ Stage 3\
                      (Health Investment Efficiency)   (Health Competitiveness Efficiency)   (Overall Efficiency)
  ------------------- -------------------------------- ------------------------------------- ----------------------
  Afghanistan1        0.179372                         0.580152                              0.393866

  Afghanistan2        0.250496                         0.463905                              0.459803

  Afghanistan3        0.243516                         0.561008                              0.486654

  Armenia1            0.188748                         1.000000                              0.762701

  Armenia2            0.643430                         0.286060                              0.731398

  Armenia3            0.254976                         0.837924                              0.765761

  Azerbaijan1         0.207980                         0.956082                              0.754376

  Azerbaijan2         0.916659                         0.191514                              0.695810

  Azerbaijan3         0.249371                         0.774038                              0.695427

  Bahrain1            0.309209                         0.429717                              0.504646

  Bahrain2            0.287332                         0.466794                              0.524639

  Bahrain3            0.157309                         0.882301                              0.502865

  Bangladesh1         0.387652                         0.715186                              0.526539

  Bangladesh2         0.603828                         0.467351                              1.000000

  Bangladesh3         0.425754                         0.737158                              0.581456

  Bhutan1             0.219310                         0.628664                              0.527021

  Bhutan2             0.235989                         0.628870                              0.585021

  Bhutan3             0.206950                         0.762345                              0.578940

  Cambodia1           0.186318                         0.911336                              0.650614

  Cambodia2           0.270786                         0.723485                              0.775593

  Cambodia3           0.251876                         0.764776                              0.710459

  China1              0.378402                         0.615274                              0.892908

  China2              0.538262                         0.396234                              0.848563

  China3              0.221638                         0.875569                              0.721108

  Georgia1            0.170703                         1.000000                              0.708993

  Georgia2            0.748990                         0.234633                              0.700777

  Georgia3            0.179522                         0.880323                              0.590384

  India1              0.420882                         0.514167                              0.832572

  India2              1.000000                         0.205447                              0.889808

  India3              0.319954                         0.721877                              0.864917

  Indonesia1          0.255831                         0.989876                              0.977166

  Indonesia2          0.329189                         0.740503                              0.946518

  Indonesia3          0.435616                         0.572582                              0.945692

  Iran1               0.342342                         0.487786                              0.646097

  Iran2               0.151942                         1.000000                              0.614447

  Iran3               0.170678                         0.869835                              0.570465

  Iraq1               0.169639                         0.974881                              0.641723

  Iraq2               0.279257                         0.558542                              0.608930

  Iraq3               0.174241                         0.804080                              0.540087

  Jordan1             0.622217                         0.195256                              0.471574

  Jordan2             0.670814                         0.176407                              0.464351

  Jordan3             0.123249                         0.878978                              0.419893

  Kazakhstan1         0.157679                         1.000000                              0.642986

  Kazakhstan2         0.932438                         0.167765                              0.608507

  Kazakhstan3         1.000000                         0.141866                              0.579401

  Kuwait1             0.094220                         1.000000                              0.409494

  Kuwait2             0.713662                         0.160848                              0.438198

  Kuwait3             0.121946                         0.898844                              0.393410

  Lao P D Republic1   0.329707                         0.522112                              0.662726

  Lao P D Republic2   0.390282                         0.536688                              0.790300

  Lao P D Republic3   0.338448                         0.623734                              0.753888

  Lebanon1            0.360734                         0.369529                              0.514827

  Lebanon2            0.678649                         0.193653                              0.498423

  Lebanon3            0.150029                         0.911588                              0.495041

  Malaysia1           0.170312                         1.000000                              0.752818

  Malaysia2           0.574866                         0.328640                              0.709799

  Malaysia3           0.191126                         0.938857                              0.647739

  Maldives1           0.134348                         1.000000                              0.578690

  Maldives2           0.597532                         0.225532                              0.505589

  Maldives3           0.111879                         0.946208                              0.382635

  Mongolia1           0.148295                         1.000000                              0.596113

  Mongolia2           0.794839                         0.224304                              0.665032

  Mongolia3           0.811569                         0.207325                              0.601636

  Myanmar1            0.535928                         0.572696                              1.000000

  Myanmar2            0.752686                         0.498871                              0.693672

  Myanmar3            0.837092                         0.453869                              0.616385

  Nepal1              0.242074                         0.928685                              0.871043

  Nepal2              0.298224                         0.819634                              0.903005

  Nepal3              0.685321                         0.376892                              0.854013

  Oman1               0.447170                         0.281217                              0.488601

  Oman2               0.706680                         0.203672                              0.534916

  Oman3               0.183312                         0.859128                              0.507564

  Pakistan1           0.373875                         0.466587                              0.678171

  Pakistan2           0.583700                         0.363226                              0.778804

  Pakistan3           0.428729                         0.555327                              0.764069

  Philippines1        0.219631                         1.000000                              0.874944

  Philippines2        0.263650                         0.857364                              0.829435

  Philippines3        0.805536                         0.299240                              0.781190

  Sri Lanka1          0.388474                         0.468811                              0.711751

  Sri Lanka2          0.377496                         0.525870                              0.731983

  Sri Lanka3          0.319852                         0.807393                              0.768124

  Syria1              0.592745                         0.307295                              0.714269

  Syria2              0.835289                         0.246034                              0.762053

  Syria3              0.339649                         0.801677                              0.813694

  Tajikistan1         0.518253                         0.435506                              0.884098

  Tajikistan2         0.861501                         0.266721                              0.838929

  Tajikistan3         0.355619                         0.730536                              0.783234

  Thailand1           0.152892                         1.000000                              0.666162

  Thailand2           0.364042                         0.484176                              0.633431

  Thailand3           0.234823                         0.855042                              0.613812

  Timor-Leste1        0.225223                         0.832965                              0.735827

  Timor-Leste2        0.621845                         0.466882                              0.544364

  Timor-Leste3        0.568697                         0.468536                              0.807044

  Turkmenistan1       0.132866                         0.857006                              0.447963

  Turkmenistan2       0.781743                         0.186355                              0.527314

  Turkmenistan3       0.372328                         0.644576                              0.682869

  Viet Nam1           0.349586                         0.519747                              0.715061

  Viet Nam2           0.523507                         0.377083                              0.700412

  Viet Nam3           0.331494                         0.754766                              0.712775

  Yemen1              0.161700                         0.872370                              0.557511

  Yemen2              0.399160                         0.452040                              0.640019

  Yemen3              0.359585                         0.690045                              0.701695
  -----------------------------------------------------------------------------------------------------------------

HIE (Health Investment Efficiency): Input → Intermediary. HCE (Health Competitiveness Efficiency): Intermediary → Output. OE (Overall Efficiency): Input → Output.

![Two-stage data envelopment analysis (DEA) structure of the study.](ijerph-17-04617-g001){#ijerph-17-04617-f001}

![Research model: Efficiency of health care investment by country.](ijerph-17-04617-g002){#ijerph-17-04617-f002}
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###### 

Example of Afghanistan's time frame (TF_1, TF_2, TF_3) for the analysis.

  Time Frame   Country          Input Variable   Intermediary Variable   Output Variable                           
  ------------ ---------------- ---------------- ----------------------- ----------------- ------------ ---------- ------------
  TF_1         Afghanistan1     Input 1          2002--2004              Intermediary 1    2005--2007   Output 1   2008--2010
  Input 2      Intermediary 2   Output 2                                                                           
  Input 3      Intermediary 3   Output 3                                                                           
  TF_2         Afghanistan2     Input 1          2005--2007              Intermediary 1    2008--2010   Output 1   2011--2013
  Input 2      Intermediary 2   Output 2                                                                           
  Input 3      Intermediary 3   Output 3                                                                           
  TF_3         Afghanistan3     Input 1          2008--2010              Intermediary 1    2011--2013   Output 1   2014--2016
  Input 2      Intermediary 2   Output 2                                                                           
  Input 3      Intermediary 3   Output 3                                                                           

Input 1: Current Health Expenditure (CHE) per Capita in Purchasing Power Parity (PPP). Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

Average efficiency of 34 countries in Asia.

  Country                   ^1^ HIE_Stage 1   ^2^ HCE_Stage 2   ^3^ OE_Stage 3
  ------------------------- ----------------- ----------------- ----------------
  Average of 34 countries   0.399             0.612             0.669

^1^ HIE (Health Investment Efficiency): Input → Intermediary. ^2^ HCE (Health Competitiveness Efficiency): Intermediary → Output. ^3^ OE (Overall Efficiency): Input → Output.
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###### 

Average values of input, intermediary, and output raw data by time frame in 34 countries.

  Input                  Average of Raw Data   Intermediary                  Average of Raw Data   Output                  Average of Raw Data
  ---------------------- --------------------- ----------------------------- --------------------- ----------------------- ---------------------
  Input 1 (2002--2004)   1064.593              Intermediary 1 (2005--2007)   0.412                 Output 1 (2008--2010)   503.547
  Input 1 (2005--2007)   1203.549              Intermediary 1 (2008--2010)   1.365                 Output 1 (2011--2013)   477.818
  Input 1 (2008--2010)   1455.074              Intermediary 1 (2011--2013)   0.229                 Output 1 (2014--2016)   453.024
  Input 2 (2002--2004)   38.819                Intermediary 2 (2005--2007)   0.141                 Output 2 (2008--2010)   110.600
  Input 2 (2005--2007)   38.926                Intermediary 2 (2008--2010)   0.300                 Output 2 (2008--2010)   96.715
  Input 2 (2008--2010)   41.574                Intermediary 2 (2011--2013)   0.074                 Output 2 (2008--2010)   86.203
  Input 3 (2002--2004)   4.775                 Intermediary 3 (2005--2007)   0.715                 Output 3 (2008--2010)   70.098
  Input 3 (2005--2007)   4.563                 Intermediary 3 (2008--2010)   2.685                 Output 3 (2008--2010)   70.851
  Input 3 (2008--2010)   4.614                 Intermediary 3 (2011--2013)   0.509                 Output 3 (2008--2010)   71.564

Input 1: Current Health Expenditure (CHE) per Capita in PPP. Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

Healthcare and welfare efficiency scores by top 10 and bottom 10 countries.

  Country               Hie (Health Investment Efficiency)   Hce (Health Competitiveness Efficiency)   Oe (Overall Efficiency)                                             
  --------------------- ------------------------------------ ----------------------------------------- ------------------------- -------------- --------------- ---------- ----------
  Top 10 countries      1                                    Kazakhstan3                               1.000000                  Philippines1   1.000000        Myanmar1   1.000000
  2                     India2                               1.000000                                  Armenia1                  1.000000       Bangladesh2     1.000000   
  3                     Kazakhstan2                          0.932438                                  Georgia1                  1.000000       Indonesia1      0.977166   
  4                     Azerbaijan2                          0.916659                                  Malaysia1                 1.000000       Indonesia2      0.946518   
  5                     Tajikistan2                          0.861501                                  Kazakhstan1               1.000000       Indonesia3      0.945692   
  6                     Myanmar3                             0.837092                                  Thailand1                 1.000000       Nepal2          0.903005   
  7                     Syria2                               0.835289                                  Iran2                     1.000000       China1          0.892908   
  8                     Mongolia3                            0.811569                                  Mongolia1                 1.000000       India2          0.889808   
  9                     Philippines3                         0.805536                                  Maldives1                 1.000000       Tajikistan1     0.884098   
  10                    Mongolia2                            0.794839                                  Kuwait1                   1.000000       Philippines1    0.874944   
  Bottom 10 countries   10                                   Thailand1                                 0.152892                  India2         0.205447        Jordan1    0.471574
  9                     Iran2                                0.151942                                  Oman2                     0.203672       Jordan2         0.464351   
  8                     Lebanon3                             0.150029                                  Jordan1                   0.195256       Afghanistan2    0.459803   
  7                     Mongolia1                            0.148295                                  Lebanon2                  0.193653       Turkmenistan1   0.447963   
  6                     Maldives1                            0.134348                                  Azerbaijan2               0.191514       Kuwait2         0.438198   
  5                     Turkmenistan1                        0.132866                                  Turkmenistan2             0.186355       Jordan3         0.419893   
  4                     Jordan3                              0.123249                                  Jordan2                   0.176407       Kuwait1         0.409494   
  3                     Kuwait3                              0.121946                                  Kazakhstan2               0.167765       Afghanistan1    0.393866   
  2                     Maldives3                            0.111879                                  Kuwait2                   0.160848       Kuwait3         0.393410   
  1                     Kuwait1                              0.094220                                  Kazakhstan3               0.141866       Maldives3       0.382635   

The above efficiency scores indicate relative efficiency. Hence, even if a country shows 1.000000 score, it does not mean that the country has the globally best efficiency. It is relatively efficient than other countries but there are still areas that can be improved.
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###### 

Comparison of the average values of input, intermediary, and output variables between the four selected countries and 34 countries.

  Country                              Input 1    Input 2   Input 3   Intermediary 1   Intermediary 2   Intermediary 3   Output 1   Output 2   Output 3
  ------------------------------------ ---------- --------- --------- ---------------- ---------------- ---------------- ---------- ---------- ----------
  ^1^ Average of 34 countries (TF_3)   1455.074   41.574    4.614     0.229            0.074            0.509            453.024    86.203     71.564
  Kazakhstan3                          1723.213   72.526    3.085     3.500            0.800            8.500            243.000    36.100     71.973
  Ratio a                              118%       174%      67%       1526%            1088%            1671%            54%        42%        101%
  ^2^ Average of 34 countries (TF_2)   1203.549   38.926    4.563     1.365            0.300            2.685            477.818    96.715     70.851
  India2                               354.734    20.511    3.648     1.300            1.000            2.900            703.000    157.200    67.368
  Ratio b                              29%        53%       80%       95%              333%             108%             147%       163%       95%
  Kazakhstan2                          1543.589   66.096    3.329     3.500            0.700            8.300            359.000    49.400     69.680
  Ratio c                              128%       170%      73%       256%             233%             309%             75%        51%        98%
  Azerbaijan2                          1655.464   15.706    5.954     3.600            0.200            8.000            289.000    98.000     71.465
  Ratio d                              138%       40%       130%      264%             67%              298%             60%        101%       101%

^1,\ 2^ The mean value was calculated as the average value for the period connected to the country time frame. Ratio a: Kazakhstan3/Average value; Ratio b: India2/Average value; Ratio c: Kazakhstan2/Average value; Ratio d: Azerbaijan2/Average value. Input 1: Current Health Expenditure (CHE) per Capita in PPP. Input 2: Domestic General Government Health Expenditure (GGHE-D) as % Current Health Expenditure (CHE). Input 3: Current Health Expenditure (CHE) as % Gross Domestic Product (GDP). Intermediary 1: Health personnel: Physicians (per 1000 population). Intermediary 2: Health personnel: Pharmacists (per 1000 population). Intermediary 3: Health personnel: Nurses and midwives personnel (per 1000 population). Output 1: Incidence of tuberculosis (per 100,000 people). Output 2: Mortality rate, under-five (per 1000 live births). Output 3: Life expectancy at birth, total (years).
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###### 

Average value of the variable in Indonesia.

  Country      Input 1   Input 2   Input 3   Intermediary 1   Intermediary 2   Intermediary 3   Output 1   Output 2   Output 3
  ------------ --------- --------- --------- ---------------- ---------------- ---------------- ---------- ---------- ----------
  Indonesia1   355.736   34.328    2.176     0.000            0.000            0.000            1036.000   104.300    67.963
  Indonesia2   544.553   31.615    2.711     1.100            0.000            0.100            1005.000   91.800     68.508
  Indonesia3   656.242   31.469    2.753     1.400            0.000            0.200            976.000    81.800     69.024
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###### 

Comparison of average values between Kuwait and 34 countries.

  Country                              Input 1    Input 2   Input 3   Intermediary 1   Intermediary 2   Intermediary 3   Output 1   Output 2   Output 3
  ------------------------------------ ---------- --------- --------- ---------------- ---------------- ---------------- ---------- ---------- ----------
  ^3^ Average of 34 countries (TF_1)   1064.593   38.819    4.775     0.412            0.141            0.715            503.547    110.600    70.098
  Kuwait1                              6305.675   79.894    3.188     0.000            0.000            0.000            113.000    33.200     73.870
  Ratio e                              592%       206%      67%       0%               0%               0%               22%        30%        105%
  ^4^ Average of 34 countries (TF_2)   1203.549   38.926    4.563     1.365            0.300            2.685            477.818    96.715     70.851
  Kuwait2                              5915.978   79.862    2.255     4.300            0.300            11.100           71.000     29.900     74.217
  Ratio f                              492%       205%      49%       315%             100%             413%             15%        31%        105%
  ^5^ Average of 34 countries (TF_3)   1455.074   41.574    4.614     0.229            0.074            0.509            453.024    86.203     71.564
  Kuwait3                              6841.809   83.322    2.853     0.000            0.000            0.000            68.000     26.300     74.576
  Ratio g                              470%       200%      62%       0%               0%               0%               15%        31%        104%

^3,\ 4,\ 5^ The mean value was calculated as the average value for the period connected to the country time frame. Ratio e: Kuwait1/Average value; Ratio f: Kuwait2/Average value; Ratio g: Kuwait3/Average value.
